Relapse and recurrent tuberculosis in the context of a national tuberculosis control programme.
- 1 May 2000
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 94 (3) , 247-249
- https://doi.org/10.1016/S0035-9203(00)90306-7
Abstract
The proportion of patients with recurrent tuberculosis (TB) is reported to be increased in TB patients with human immunodeficiency virus (HIV) infection after they have completed treatment. Despite rising HIV seroprevalence amongst TB patients in Malawi, notifications of patients with relapse smear-positive pulmonary TB (PTB) and recurrent smear-negative TB have remained stable during the past 12 years. We suspected that patients with recurrent or relapse TB were being missed under routine programme conditions. Forty-three hospitals in Malawi were visited in 1999, and TB inpatients who had been registered as ‘new’ cases in the TB register and treatment card were interviewed about previous episodes of TB. A previous history of TB was elicited in 94 (7·5%) of 1254 patients who were being treated as new cases. Compared with patients with smear-positive PTB, a previous episode of TB was significantly more common in patients with smear-negative PTB (OR 3·5, [95% CI 2·1–5·7], P < 0·001) and patients with extrapulmonary TB (OR 2·0, [95% CI 1·1–3·7], P < 0·05). Of 94 patients with a previous episode of TB, 76 had completed treatment and 18 had defaulted from treatment during this episode. Patients with recurrent or relapse TB are being incorrectly registered within the Malawi TB Control Programme, and in the case of smear-positive PTB patients this is associated with administration of incorrect treatment. Measures have been put in place to rectify the situation, and further operational research is planned to monitor treatment outcomes of patients with recurrent smear-negative TB.Keywords
This publication has 8 references indexed in Scilit:
- HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-upTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997New England Journal of Medicine, 1998
- An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, MalawiTubercle and Lung Disease, 1995
- Two-year follow-up of persons with HIV-1− and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West AfricaAIDS, 1995
- Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfectionTubercle and Lung Disease, 1994
- Increased recurrence of tuberculosis in HIV-1-infected patients in KenyaThe Lancet, 1993
- Increased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, ZaireAmerican Review of Respiratory Disease, 1991
- HIV seropositivity and tuberculosis in a rural Malawi hospitalTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990